EZH2-IN-2 is a EZH2 inhibitor extracted from patent WO2018133795A1, Compound Example 69, with an IC50 of 64 nM. EZH2-IN-2 can be used for the research of cancer or precancerous condition related to EZH2 activity. References: [1]. LIU, Qing Song, et al. Ezh2 inhibitor and use thereof. WO2018133795A1.

纯度：≥98%

CAS：2238821-31-1